Background: Evidence about the association between types of oral anticoagulants and
hazards of diabetes complications is limited in patients with atrial fibrillation (AF) and
diabetes mellitus (DM). Objective: To compare the hazards of diabetes complications and
mortality between patients with AF and DM receiving non–vitamin K antagonist oral
anticoagulants (NOACs) and those receiving warfarin. Design: A retrospective cohort study.
Setting: Nationwide data obtained from Taiwan's National Health Insurance Research …

Introduction: Globally, cardiovascular disease is the main contributor to mortality, accounting
for about 17.5 million deaths, or 46.2% of deaths from non-communicable diseases.
Objectives: The main objective of the study is to find the diabetes-related complications and
mortality in patients with atrial fibrillation receiving different oral anticoagulants. Material and
methods: This cross sectional study was conducted in DHQ Teaching Hospital Sahiwal
during July 2021 till December 2021. The data were collected from 120 diabetic patients …